Inhibition of NOS II prevents cardiac dysfunction in myocardial infarction and congestive heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Saito, Takayuki ^a,b,c   Hu, Fu ^a,b,c   Tayara, Lara ^a,b,c   Fahas, Linda ^a,b,c   Shennib, Hani ^a,b,c   Giaid, Adel ^a,b,c,d  

^a CHUM St Luc   (Canada)

^b Medicine   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

S methylisothiourea

Indexed keywords

NITRATE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; S METHYLPSEUDOTHIOUREA; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; HEART DISEASE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; LONG TERM CARE; LUNG FLUID; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0036302721     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00596.2001     Document Type: Article

References (46)

1. Production of oxidative products of nitric oxide in infarcted human heart
2. Oxidation products of nitric oxide, NO2 and NO 3, in plasma after experimental myocardial infarction
3. Abnormal contractile function due to induction of nitric oxide synthase in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium
4. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia
5. Nitric oxide attenuates cardiac myocyte contraction
6. Inducible nitric oxide synthase is present within human arterosclerotic lesions and promotes the formation and activity of peroxynitrite
7. Dexamethasone inhibits the expression of an inducible nitric oxide synthase in infarcted rabbit myocardium
8. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice
9. Negative inotropic effects on the heart mediated by nitric oxide
10. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure
11. Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction
12. Potent and selective inhibition of human nitric oxide synthases
13. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene
14. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure. Potentiation of β-adrenergic inotropic responsiveness
15. Expression of inducible nitric oxide synthase in human heart failure
16. Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning
17. Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats
18. Nitric oxide and cardiac function
19. Nitric oxide synthases in mammals
20. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats
21. Myocardial contractile response to nitric oxide and cGMP
22. Protective effects of calpain inhibitor for prolonged hypothermic cardiac preservation
23. Inhibition of cyclooxygenase-2 improves cardiac function in myocardial infarction
24. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction
25. Effects of calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure
26. The role of nitric oxide in cardiac depression induced by interleukin-1β and tumor necrosis factor α
27. Isothiourease: Potent inhibitors of nitric oxide synthase with variable isoform selectivity
28. Protective effects of cyclosporin-A in splanchnic artery occlusion shock
29. Induction of apoptosis in myocardial infarction and its possible relationship to nitric oxide synthase in macrophages
30. The pathophysiological role of peroxynitrite in shock, inflammation and ischemia-reperfusion injury
31. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase
32. Apoptosis and increased expresion of nitric oxide synthase in human allograft rejection
33. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits
34. Lipopolysaccharides and cytokines downregulate the angiotensin II type 2 receptor in rat cardiac fibroblasts
35. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension
36. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
37. In vivo pharmacological evaluation of two novel type II (inducible) nitric oxide synthase inhibitors
38. Differential regulation of cardiac expression of IL-6 and TNF-α by A2- and A3-adenosine receptors
39. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase
40. Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction
41. Aminoguanidine inhibits inducible NOS and reverses cardiac dysfunction late after ischemia and reperfusion-implications for iNOS-mediated myocardial stunning
42. S-methylisothiourea inhibits inducible nitric oxide synthase and improves left ventricular performance after acute myocardial infarction
43. Selective modulation of inducible nitric oxide synthase isozyme in myocardial infarction
44. Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: Evidence for a late phase of nitric oxide-mediated reperfusion injury
45. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection: Evidence from pharmacological inhibition and gene knockout mice
46. Myocardial ischemia/reperfusion injury in the inducible nitric oxide synthase knockout mice